BMO Capital upgraded bluebird bio (NASDAQ: BLUE) from Market Perform to Outperform with a price target of $108.00 (from $83.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE